Preferred therapies for neovascular age-related macular degeneration
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preferred therapies for neovascular age-related macular degeneration
Authors
Keywords
-
Journal
CURRENT OPINION IN OPHTHALMOLOGY
Volume 23, Issue 3, Pages 182-188
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-03-24
DOI
10.1097/icu.0b013e328352411c
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bevacizumab for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen: Clinical and Economic Impact
- (2011) Gary Shienbaum et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study
- (2011) Frank G. Holz et al. OPHTHALMOLOGY
- The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed Dosing
- (2011) Jeffrey S. Heier et al. OPHTHALMOLOGY
- ONE-YEAR OUTCOMES OF LESS FREQUENT BEVACIZUMAB IN AGE-RELATED MACULAR DEGENERATION
- (2011) Kenan Sonmez et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- ONE-YEAR RESULTS OF A FLEXIBLE REGIMEN WITH RANIBIZUMAB THERAPY IN MACULAR DEGENERATION
- (2011) Luis Arias et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- THREE-YEAR SAFETY AND VISUAL ACUITY RESULTS OF EPIMACULAR 90STRONTIUM/90YTTRIUM BRACHYTHERAPY WITH BEVACIZUMAB FOR THE TREATMENT OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION
- (2011) Marcos P Ávila et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intravitreal bevacizumab alone versus in combination with photodynamic therapy for the treatment of neovascular maculopathy in patients aged 50 years or older: 1-year results of a prospective clinical study
- (2010) Jong Yoon Lim et al. ACTA OPHTHALMOLOGICA
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2
- (2010) Prema Abraham et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Combination therapy in exudative age-related macular degeneration: visual outcomes following combined treatment with photodynamic therapy and intravitreal bevacizumab
- (2010) Michael J. Wan et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Let us wake the nation on the treatment for age-related macular degeneration
- (2010) Gary Brown et al. CURRENT OPINION IN OPHTHALMOLOGY
- A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular DegenerationClinical and Economic Impact
- (2010) Omesh P. Gupta et al. OPHTHALMOLOGY
- ANATOMICAL BENEFIT FROM RANIBIZUMAB TREATMENT OF PREDOMINANTLY CLASSIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN THE 2-YEAR ANCHOR STUDY
- (2010) Srinivas R Sadda et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Effects of Ranibizumab in Patients with Subfoveal Choroidal Neovascularization Attributable to Age-related Macular Degeneration
- (2009) Simon P. Rothenbuehler et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Results of One-Year's Treatment with Ranibizumab for Exudative Age-related Macular Degeneration in a Clinical Setting
- (2009) Salomon Y. Cohen et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- (2009) P Mitchell et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration
- (2009) C. Costagliola et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A randomised trial of bevacizumab and reduced light dose photodynamic therapy in age-related macular degeneration: the VIA study
- (2009) M. J. Potter et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal bevacizumab (Avastin) for age-related macular degeneration: a critical analysis of literature
- (2009) S Jyothi et al. EYE
- A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration
- (2009) David S. Boyer et al. OPHTHALMOLOGY
- Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration
- (2009) Hajir Dadgostar et al. OPHTHALMOLOGY
- A Phase I Study of Intravitreal Vascular Endothelial Growth Factor Trap-Eye in Patients with Neovascular Age-Related Macular Degeneration
- (2009) Quan Dong Nguyen et al. OPHTHALMOLOGY
- TWELVE-MONTH SAFETY AND VISUAL ACUITY RESULTS FROM A FEASIBILITY STUDY OF INTRAOCULAR, EPIRETINAL RADIATION THERAPY FOR THE TREATMENT OF SUBFOVEAL CNV SECONDARY TO AMD
- (2009) MARCOS P. ÁVILA et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- A prospective study on intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration of different durations
- (2008) Peep V. Algvere et al. ACTA OPHTHALMOLOGICA
- Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties
- (2008) Alan F. Cruess et al. ACTA OPHTHALMOLOGICA
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration
- (2008) M P Avila et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study
- (2008) G. Weigert et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: A One-year Prospective Study
- (2007) Ziad F. Bashshur et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now